Vanderbilt University: Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial -December 05, 2023 at 05:30 am EST : vimarsana.com

Vanderbilt University: Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial -December 05, 2023 at 05:30 am EST

A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical...

Related Keywords

, Williamk Warren Jr , Aaron Bender , Robert Lenz , Daniel Diermeier , Olivier Boutaud , Colleen Niswender , Kayla Temple , P Jeffrey Conn , Alison Gregro , Carrie Jones , Padma Raghavan , Craig Lindsley , Vice Provost For Research , Williamk Warren Foundation , Warren Center , Neumora Therapeutics Inc , University Professor , Drug Administration , National Institutes Of Health , Neuroscience Drug Discovery , Director Emeritus , Jeffrey Conn , Investigational New Drug , Therapeutics Inc , Homer Style Odyssey , Vice Provost , Technology Transfer , News Publishing , Markets ,